The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now.
The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now.
Clin Adv Hematol Oncol. 2015 Sep;13(9):580-3
Authors: VanderWeele DJ
PMID: 26452188 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research